FOPE–CIPI–DCGI Meet Strengthens Industry-Regulator Collaboration in Indian Pharma

FOPE–CIPI–DCGI Meet Strengthens Industry-Regulator Collaboration in Indian Pharma

By, Admin 12 August 2025

New Delhi – The Federation of Pharma Entrepreneurs (FOPE), in collaboration with the Confederation of Indian Pharmaceutical Industry (CIPI), partnered with the Drugs Controller General of India (DCGI) Office to host a high-level interactive meeting aimed at fostering meaningful dialogue, regulatory alignment, and strategic partnerships within the pharmaceutical sector.

Participation and Representation

  • 17 FOPE state representatives participated
  • Around 230 industry leaders from across India attended
  • Meeting aimed at:
    - Enhancing regulatory alignment
    - Supporting industry growth
    - Addressing key challenges faced by pharmaceutical stakeholders

Opening Remarks

B.R. Sikri, Chairman, FOPE, set a purposeful tone for the proceedings, stressing:

  • The need for stronger industry–regulator collaboration
  • Joint efforts in addressing contemporary challenges and emerging opportunities

Keynote by the DCGI

Dr. Rajeev Singh Raghuvanshi, DCGI and Chief Guest, shared:

  • Regulatory priorities for the sector
  • Emphasis on innovation and modernization
  • The shared responsibility of industry and regulators in ensuring:
    - Drug quality
    - Safety
    - Accessibility

Insights from Industry Leaders

  • Dr. A.K. Pradhan, Retd JDCG(I), spoke about:
    - The critical role of senior management in shaping the industry’s future
  • FOPE members announced a Formula Donation and Technology Transfer Initiative to:
    - Drive innovation
    - Enhance drug accessibility

Strategic Partnership Milestone

  • Signing of a Memorandum of Understanding (MoU) between:
    - FOPE and Welzo Research & Development
  • Objective:
    - Facilitate ground-breaking product development
    - Enable seamless technology transfer

Dynamic Engagements

Harish Jain Manawat, President, FOPE:

  • Led discussions with DCGI Dr. Raghuvanshi and senior CDSCO officers
  • Focused on:
    - Innovative ideas
    - Nurturing new partnerships

Event Highlights and Closing

  • Programme anchored by Jatish Seth, Secretary General, CIPI
  • Special address by R.K. Jain, Chairman, CIPI
  • Closing remarks included:
    - Unwavering participant support
    - Recognition and honouring of dignitaries, speakers, donors, and sponsors by Vinod Kalani, Co-Chairman, FOPE

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!